Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new treatment for bone and cartilage reconstruction and reinforcement.
Promethera® Biosciences, a spin-off company of the Université catholique de Louvain, and Sopartec, the technology transfer office of the Université catholique de Louvain, presents a new hepatocyte-like cell in vitro model.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new urinary biomarker that enables an early and sensitive detection of renal dysfunction.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new tool for the differential diagnosis of rheumatic conditions.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new method for quantification of biomarkers on histopathological slides
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new therapeutic strategy for cardiovascular diseases.
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a unique patented technology to assist upper limb’s patient in stroke rehabilitation process
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new method for increasing the size of plants or plant organs
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new faster and accurate method for real time brachytherapy dosimetry
Sopartec, the technology transfer company of the Université catholique de Louvain (UCL), presents a new bioreactof for mass production of high quality arbuscular mycorrhizal fungi inoculants